117 related articles for article (PubMed ID: 16374130)
1. Normal uptake of F-18 FDG in the sublingual gland.
Bogsrud TV; Karantanis D; Lowe VJ
Clin Nucl Med; 2006 Jan; 31(1):50. PubMed ID: 16374130
[No Abstract] [Full Text] [Related]
2. Comparison of F-18 FDG to I-123 and I-131 scans in thyroid carcinoma.
Bakheet SM; Powe JE; Hammami MM; Ahmed M
Clin Nucl Med; 1997 Jun; 22(6):438-9. PubMed ID: 9193832
[No Abstract] [Full Text] [Related]
3. Iodine-123 uptake in vertebral haemangiomas in a patient with papillary thyroid carcinoma.
Khan S; Dunn J; Strickland N; Al-Nahhas A
Nucl Med Rev Cent East Eur; 2008; 11(1):30-3. PubMed ID: 19173186
[TBL] [Abstract][Full Text] [Related]
4. Metastatic parotid tumor: a rare presentation for papillary carcinoma of thyroid.
Malhotra G; Nair N; Awasare S; Baghel NS
Clin Nucl Med; 2007 Jun; 32(6):488-90. PubMed ID: 17515766
[No Abstract] [Full Text] [Related]
5. Radioiodine uptake by metastatic nonthyroidal adenocarcinoma of the lung in a patient with papillary thyroid carcinoma.
Sohn MH; Kim MW; Lim ST; Lee NR; Song EK; Yim CY
Clin Nucl Med; 2005 Apr; 30(4):269-70. PubMed ID: 15764888
[TBL] [Abstract][Full Text] [Related]
6. [Pathological thyroid uptake in Cushing's syndrome: an unexpected finding].
Civantos Modino S; Montaño Martínez J; Pavón de Paz I; Guijarro de Armas G; Monereo Megías S
Endocrinol Nutr; 2011; 58(6):315-7. PubMed ID: 21497569
[No Abstract] [Full Text] [Related]
7. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N
J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
[TBL] [Abstract][Full Text] [Related]
8. Abnormal lung iodine-131 uptake in a patient with cystic fibrosis and papillary thyroid carcinoma.
Modoni S; Crocetti U; Torlontano M; Urbano N
Thyroid; 2005 Jan; 15(1):89-90. PubMed ID: 15687830
[No Abstract] [Full Text] [Related]
9. [Thymic uptake of 18FFDG following radioiodine ablation therapy].
Albalá González MD; Martínez Gimeno E; Cárdenas Negro C; Allende Riera A; Cabello García D; De Sequera Rahola M; Uña Gorospe JA
Rev Esp Med Nucl; 2011; 30(5):314-6. PubMed ID: 21342725
[TBL] [Abstract][Full Text] [Related]
10. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
Rashid K; Johns W; Chasse K; Walker M; Gupta SM
Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
[No Abstract] [Full Text] [Related]
11. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
12. Retained esophagus uptake of iodine-131 in a patient with papillary thyroid carcinoma mimicking a mediastinal mass.
Kurtaran A; Ozer S; Kienast O; Dobrozemsky G; Dudczak R
Thyroid; 2003 Feb; 13(2):225. PubMed ID: 12699600
[No Abstract] [Full Text] [Related]
13. Focal pelvic uptake in 18F-FDG PET due to a contraceptive device; a potential pitfall easily unmasked by PET-CT.
Fuechsel FG; Weidner S; Krause T
Nuklearmedizin; 2006; 45(4):N42-3. PubMed ID: 16969953
[No Abstract] [Full Text] [Related]
14. Papillary thyroid cancer with metastasis to the skin.
Junik R; Kłubo-Gwieździńska J; Zuchora Z; Zmyslowski W
Clin Nucl Med; 2006 Jul; 31(7):435-6. PubMed ID: 16785820
[No Abstract] [Full Text] [Related]
15. [18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I].
Feine U; Lietzenmayer R; Hanke JP; Wöhrle H; Müller-Schauenburg W
Nuklearmedizin; 1995 Aug; 34(4):127-34. PubMed ID: 7675641
[TBL] [Abstract][Full Text] [Related]
16. Iodine-131 uptake in focal bronchiectasis mimicking metastatic thyroid cancer.
Song HC; Heo YJ; Kim SM; Bom HS
Clin Nucl Med; 2003 Apr; 28(4):351-2. PubMed ID: 12642729
[No Abstract] [Full Text] [Related]
17. I-131 localization in hematocolpos: a differential diagnosis consideration for pelvic I-131 uptake.
Mattern M; Staab E
Clin Nucl Med; 2007 Aug; 32(8):659-60. PubMed ID: 17667447
[TBL] [Abstract][Full Text] [Related]
18. Detection of unsuspected metachronous second primary malignancy giving rise to supposed "non-iodine avid metastasis" in differentiated thyroid carcinoma.
Basu S; Nair N; Shet T
Clin Nucl Med; 2007 Aug; 32(8):655-8. PubMed ID: 17667446
[TBL] [Abstract][Full Text] [Related]
19. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Dennis K; Hay JH; Wilson DC
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
[TBL] [Abstract][Full Text] [Related]
20. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma.
Alnafisi NS; Driedger AA; Coates G; Moote DJ; Raphael SJ
J Nucl Med; 2000 Jun; 41(6):1010-5. PubMed ID: 10855626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
